Mercury Capital

Clark Perkins, the firm's founder, serves as Chairman and CEO. He is supported by three Partners — Ben Hawter, Chris Criddle and Oliver Tompkins — and a team of Investment Directors. Investment Committees and Board representation are typically structured at both the fund and portfolio-company levels, with Perkins and the Partners holding multiple portfolio-company directorships.

The firm draws on the networks of its senior team, many of whom previously worked at Goldman Sachs JBWere, McKinsey, CVC Capital Partners and Pacific Equity Partners. Its portfolio companies also serve as platforms for add-on acquisitions, as demonstrated by the roll-up of landscape services businesses into Green by Nature and the merger that created Re.Group.

Mercury Capital is a private equity fund manager, not a family office. It has raised three successive closed-end funds from institutional and other external limited partners — a A$120 million fund in 2010, a A$300 million fund in 2015, and a A$600 million fund in 2018.

Mercury executes direct control and minority equity investments in operating companies, mostly in Australia and New Zealand. There is no public evidence that it makes fund commitments or acts as a fund-of-funds investor. Its deals consistently involve taking substantial, board-represented minority or control stakes.

The firm has not publicly disclosed explicit avoidance. However, its portfolio shows no exposure to early-stage venture capital, deep tech, mining extraction, or heavy industrials. Its preference is for businesses with recurring or regulated revenue streams in services, healthcare, education, and domestic infrastructure.

Mercury Capital manages blind-pool, closed-end funds raised from external limited partners. Clark Perkins founded the firm in 2010 after leading Goldman Sachs JBWere's private equity division, but the firm does not publicly disclose its LP base.

The firm frequently invests alongside management teams, founders and other shareholders, as seen in Avive Health (partnered with Foundation Doctor Shareholders) and Nexus Day Hospitals (partnered with approximately 70 shareholder doctors). It does not advertise a formal co-investment program for external LPs, but its deal structures routinely accommodate operating partners and minority co-investors.